Pregled bibliografske jedinice broj: 300023
Detection of multidrug resistance (MDR) in acute leukemias
Detection of multidrug resistance (MDR) in acute leukemias // Periodicum Biologorum 97 (S1) / Branko Vitale (ur.).
Zagreb: Hrvatsko prirodoslovno društvo, 1995. (poster, nije recenziran, sažetak, znanstveni)
CROSBI ID: 300023 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Detection of multidrug resistance (MDR) in acute leukemias
Autori
Ajduković, Radmila ; Svoboda Beusan, Ivna ; Labar, Boris
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Periodicum Biologorum 97 (S1)
/ Branko Vitale - Zagreb : Hrvatsko prirodoslovno društvo, 1995
ISBN
0031-5362
Skup
1995 Annual Meeting of the Croatian Immunological Society
Mjesto i datum
Zagreb, Hrvatska, 23.11.1995. - 24.11.1995
Vrsta sudjelovanja
Poster
Vrsta recenzije
Nije recenziran
Ključne riječi
MDR; Pgp; AML; All; Flow cytometry
Sažetak
The MDR phenotype is caused by enhanced cellular druf+g efflux due to increased reactivity of membrane-associated P.glycoprotein (Pgp). To evaluate the correlation between Pgp expression and the response to chemotherapy we analyzed 30 patients: 26 with acute myeloid (AML) and 4 with acute lymphoblastic (ALL) leukemias. Seventeen patients were at initial presentation (de novo)and thirteen during residual disease (secondary). Whole blood samples were labelled with anti-Pgp mAb P-glycoCHEK C-219 (centocor Diagnostic) and measured by flow cytometry. According to FSC/SSC dot plot light scatter properties of 20000 cells, three of four populations (lymphocytes, granulocytes, monocytes and lympho/monoblasts) were gated. In each gate 5000 events were recorded. The number of Pgp cells within gates varied widely. Increased Pgp expression was found on granulocytes in AML and on lymphocytes in ALL. Fifteen patients were reinvestigated after first induction cycle and among them four patients were tested twice, one four and one five times. The study is still in progress, so remission is achieved by now in eight patients only. In all remission samples Pgp cells decreased, but the C-219 epitope is still present on granulocytes with high fluorescence intensity. Although elevated Pgp levels have been observed in AML at diagnosis, the expression in resistant AMP patients was generally higher. The result suggest that in patients with acute leukemias increased Pgp expression could be a bad prognostic factor.
Izvorni jezik
Engleski
Znanstvena područja
Biologija